Prostate cancer (PCa) is a leading malignancy among men globally, with varying incidence across regions.
While high-income countries have effectively controlled PCa through early detection and treatment, middle- and low-income regions, including China, are experiencing rising incidence rates.
Understanding these trends is crucial for effective prevention and management.
